Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate added to levobupivacaine for rectus sheath block in colorectal laparotomy
ACTRN12626000376347Phase 4Not yet recruiting
- Sponsor
- University Hospital Center Sestre milosrdnice
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of magnesium sulfate and levobupivacaine in postoperative pain (2 arms), sponsored by University Hospital Center Sestre milosrdnice. Primary endpoint: Time from rectus sheath block to numerical pain rating scale greater than 3. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
magnesium sulfatelevobupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12626000376347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000376347.